What is wrong with stopping at human error?
- AIt fails to identify who was responsible
- BThe next person will make the same mistake
- CIt takes longer than a full analysis
- DIt cannot be documented for the record
Mock paper #1
A full paper drawn to the blueprint. Answers and worked explanations are at the back of this file.
Single-user licence. You may print this file and write on it. You may not redistribute, resell or post it. © Sitonce 2026.
Sit this the way you will sit the real one. A mock done in pieces over three evenings measures your notes, not your recall.
| Area | Questions | Share |
|---|---|---|
| Medications | 28 | 35% |
| Patient Safety and Quality Assurance | 19 | 24% |
| Order Entry and Processing | 18 | 23% |
| Federal Requirements | 15 | 19% |
| Total | 80 | 100% |
Circle one letter for each question.
80 questions. 110 minutes.
What is wrong with stopping at human error?
In what two forms must the identifier appear?
What is a drug-laboratory interaction?
The paper carries one for every question, at the back. These are the three above.
Answer: B - The next person will make the same mistake
Because The correct answer is: The next person will make the same mistake. See PTCB Knowledge Reference sec. 3. PTCB Knowledge Reference sec. 3
Where the other options lead
Answer: C - Human-readable and machine-readable
Because The correct answer is: Human-readable and machine-readable. See 21 CFR 201.25. 21 CFR 201.25
Where the other options lead
Answer: C - A drug changes a test result rather than the patient
Because The correct answer is: A drug changes a test result rather than the patient. See Drug reference ch. 4 (drug interactions). Drug reference ch. 4 (drug interactions)
Where the other options lead
PTCB Exam: the whole syllabus taught, the questions that test it, 5 timed mocks, and all 6 PDFs to print.